PT - JOURNAL ARTICLE AU - Kaivosaari, Sanna AU - Toivonen, Päivi AU - Aitio, Olli AU - Sipilä, Julius AU - Koskinen, Mikko AU - Salonen, Jarmo S. AU - Finel, Moshe TI - Regio- and Stereospecific <em>N</em>-Glucuronidation of Medetomidine: The Differences between UDP Glucuronosyltransferase (UGT) 1A4 and UGT2B10 Account for the Complex Kinetics of Human Liver Microsomes AID - 10.1124/dmd.108.021709 DP - 2008 Aug 01 TA - Drug Metabolism and Disposition PG - 1529--1537 VI - 36 IP - 8 4099 - http://dmd.aspetjournals.org/content/36/8/1529.short 4100 - http://dmd.aspetjournals.org/content/36/8/1529.full SO - Drug Metab Dispos2008 Aug 01; 36 AB - Medetomidine is a chiral imidazole derivate whose dextroenantiomer is pharmacologically active. The major metabolic pathway of dexmedetomidine [(+)-4-(S)-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole] in humans is N-glucuronidation at the imidazolate nitrogens. We have purified the N3- and N1-glucuronides of dexmedetomidine, termed DG1 and DG2, respectively, according to their elution order in liquid chromatography and determined their structure by 1H nuclear magnetic resonance (NMR). Studying medetomidine glucuronidation by human liver microsomes (HLMs) and recombinant UDP glucuronosyltransferase (UGT) 1A4 indicated that another human UGT plays a major role in these activities. We now demonstrate that this enzyme is UGT2B10. HLMs catalyzed DG1 and DG2 formation, at a ratio of 3:1, with two-enzyme kinetics that contain both a high-affinity component, Km1 values of 6.6 and 8.7 μM, and a low-affinity component, Km2 values &gt; 1 mM. The DG1/DG2 ratio in the case of UGT2B10 was lower, 1.4:1, whereas the substrate affinity for both reactions was high, Km values of 11 and 16 μM. UGT1A4 produced mainly DG1 (DG1/DG2 ratio of 6.6:1) at low substrate affinities, Km values above 0.6 mM, but superior expression-normalized Vmax values. Levomedetomidine [(-)-4-(R)-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole] glucuronidation by HLMs yielded mostly the N3-glucuronide (LG1, structure determined by NMR), with monophasic kinetics and a Km value of 14 μM. The activity of UGT1A4 toward levomedetomide was low and generated both LG1 and LG2, whereas UGT2B10 exhibited relatively high activity and sharp regioselectivity, yielding only LG1, with a Km value of 7.4 μM. The results highlight the contribution of UGT2B10 to medetomidine glucuronidation and its potential importance for other N-glucuronidation reactions within the human liver. The American Society for Pharmacology and Experimental Therapeutics